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1 While the number of possible therapeutic targets increases rapidly, translation 
into evidence based treatment of pulmonary hypertension in the newborn lags 
behind. (this thesis) 
 
2 Expression pattern of VEGF in human lung development is probably HIF-2 
regulated and important in the pathophysiology of CDH. (this thesis) 
 
3 Hyperoxia will decrease the efficacy of PDE5 inhibition to lower the 
pulmonary vascular resistance. (this thesis) 
 
4 Excessive stabilization of the extracellular matrix by increased lysyl oxidase 
activity might impede normal matrix remodeling that is required for pulmonary 
alveolarization. (this thesis) 
 
5 Pulmonary vascular disease in CDH consists of decreased pulmonary vascular 
development, abnormal vascular reactivity and disordered vascular 
remodeling. (this thesis) 
 
6 The phytopharmica, ‘San-Huang-Xie-Xin-Tang’ attenuated U46619 induced 
pulmonary hypertension. (HH Tsai et al. J Ethnopharmacol. 2008) 
 
7 CDH fetuses have decreased lung tissue perfusion, which is associated with 
decreased lung growth. (O Moreno-Alvarez et al. Ultrasound Obstet Gynecol 
2010) 
 
8 Dichloroacetate has been shown to reverse both cancer growth and pulmonary 
hypertension. (ED Michelakis et al. Am J Physiol Heart Circ Physiol 2008) 
 
9 Nowadays society is in need of physician-scientists, who bridge the gap 
between research laboratory and the patients’ bedside. (S. Archer Eur Heart 
Journal 2007)  
 
10  Imagination is more important than knowledge. (Albert Einstein) 
 
11 Daar alleen kan liefde wonen, daar alleen is het leven goed, waar men vrij en 
ongedwongen alles voor elkander doet. 
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